市場調查報告書
商品編碼
1379198
2023-2028 年按產品、材料、最終用戶(製藥和生物技術公司、合約製造組織、合約研究組織、學術和研究機構)和地區分類的藥品瓶蓋和密封件市場報告Pharmaceutical Caps and Closures Market Report by Product, Material, End User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028 |
2022年全球藥品瓶蓋和瓶蓋市場規模達34億美元。展望未來, IMARC Group預計到 2028 年市場規模將達到 57 億美元,2022-2028 年複合年成長率 (CAGR) 為 9.0%。癌症、糖尿病、氣喘和心血管疾病等慢性和急性疾病的盛行率不斷上升,對安全有效包裝的需求不斷增加,以及兒童安全包裝解決方案的推出是推動市場發展的一些關鍵因素。
藥品瓶蓋和封口是氣密密封產品,可保護藥品免受灰塵、濕氣和不利氣候條件的影響。它們由不同的金屬材料和聚合物製成,例如高密度聚丙烯(HDPP)和聚乙烯。它們可以保護產品免受環境和微生物的破壞,從而幫助產品長時間保持新鮮。它們還增強了產品的美感,並使從一處運輸到另一處時的處理變得方便。此外,它們還可以透過避免微生物侵襲和污染的機會,幫助最大限度地減少浪費並延長包裝藥物的保存期限。因此,全球對藥品瓶蓋和瓶蓋的需求不斷增加。
由於久坐的生活方式、老年人口的增加和不健康的飲食模式,各種急慢性疾病的盛行率增加,例如高血壓、糖尿病、氣喘、肥胖、慢性阻塞性肺病、肌肉骨骼疾病和牙齒問題。這是推動全球對瓶蓋和瓶蓋等藥品包裝解決方案需求的關鍵因素之一。對安全有效的包裝解決方案不斷成長的需求也鼓勵了藥品瓶蓋和密封件市場的創新。除此之外,對兒童安全包裝解決方案的需求不斷成長,以防止兒童意外食用,這是支持市場成長的另一個主要因素。此外,隨著個人支出能力的增加以及醫院、門診手術中心 (ASC) 和其他醫療中心的擴張,全球對藥品的需求正在增加。此外,產業投資者越來越關注利用先進製造技術生產高精度、高效率的輕質瓶蓋和瓶蓋,這提供了良好的市場前景。除此之外,用塑膠製造的瓶蓋和密封件由於經濟、耐用且耐腐蝕而在製藥業獲得了巨大的吸引力。此外,領先的市場參與者正在開發具有卓越耐化學性能的不同形狀和尺寸的客製化產品,以滿足最終用戶的要求。他們還專注於開發由可回收或可生物分解材料製成的永續封閉解決方案,以減少對環境的影響和產品開發成本,預計這將推動市場成長。
The global pharmaceutical caps and closures market size reached US$ 3.4 Billion in2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028 exhibiting a growth rate (CAGR) of 9.0% during 2022-2028. The growing prevalence of chronic and acute conditions, such as cancer, diabetes, asthma, and cardiovascular diseases, rising need for safe and effective packaging, and the introduction of child-proof packaging solution represent some of the key factors driving the market.
Pharmaceutical caps and closures are air-tight sealing products that protect pharmaceutical items from dust, moisture, and unfavorable climatic conditions. They are made up of different metallic materials and polymers, such as high-density polypropylene (HDPP) and polyethylene. They help keep the content fresh for an extended period by protecting products from environmental and microbiological spoilage. They also enhance product aesthetics and make handling convenient during transportation from one place to another. In addition, they assist in minimizing wastage and increasing the shelf-life of packed medicines by averting the chances of microbial attacks and contamination. As a result, the demand for pharmaceutical caps and closures is increasing across the globe.
Due to sedentary lifestyles, rising geriatric population, and unhealthy dietary patterns, there is an increase in the prevalence of various acute and chronic conditions, such as hypertension, diabetes, asthma, obesity, COPD, musculoskeletal disorders, and dental problems. This represents one of the key factors catalyzing the demand for pharmaceutical packaging solutions like caps and closures across the globe. The escalating demand for safe and effective packaging solutions is also encouraging innovations in the pharmaceutical caps and closures market. Along with this, the rising need for child-proof packaging solutions to prevent kids from accidental consumption is another major factor supporting the growth of the market. Furthermore, the demand for pharmaceutical products is increasing worldwide with the increasing expenditure capacity of individuals and the expansion of hospitals, ambulatory surgical centers (ASCs), and other healthcare centers. Moreover, rising focus of industry investors on utilizing advanced manufacturing techniques for producing lightweight caps and closures with high precision and efficiency is offering a favorable market outlook. Apart from this, caps and closures manufactured with plastic are gaining immense traction in the pharmaceutical industry as they are economical, durable, and resistant to corrosion. Furthermore, leading market players are developing customized products in different shapes and sizes with superior chemical resistance properties to meet end-user requirements. They are also focusing on the development of sustainable closure solutions made from recyclable or biodegradable materials to reduce the environmental impact and product development costs, which is anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical caps and closures market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, material, and end user.
Screw-on Caps
Dispensing Caps
A detailed breakup and analysis of the pharmaceutical caps and closures market based on the product has also been provided in the report. This includes screw-on caps and dispensing caps.
PP
HDPE
LDPE
The report has provided a detailed breakup and analysis of the pharmaceutical caps and closures market based on the material. This includes PP, HDPE, and LDPE.
Pharmaceutical and Biotechnology Companies
Contract Manufacturing Organizations (CMO)
Contract Research Organizations (CRO)
Academic and Research Institutes
A detailed breakup and analysis of the pharmaceutical caps and closures market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, contract manufacturing organizations (CMO), contract research organizations (CRO), and academic and research institutes.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical caps and closures on account of the highly advanced and robust healthcare infrastructure, presence of well-established pharmaceutical industry, increasing investment in the healthcare industry, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global pharmaceutical caps and closures market. Detailed profiles of all major companies have been provided. Some of the companies covered include Amcor PLC, Aptar Group Inc., Bericap GmbH and Co. KG, Berry Global Group Inc., Closure Systems International Inc., Comar LLC, MJS Packaging, Pano Cap Canada Ltd, Saudi Basic Industries Corporation (Saudi Arabian Oil Co.), Tecnocap S.p.A., United Caps Luxembourg S.A., etc. Kindly note that this only represents a partial list of companies and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.